Zhijian Kuang & Chun‐Ming Wong. (2022). Targeting CDK12 is a novel therapeutic strategy through disrupting oncogene associated super‐enhancers in metastatic colorectal cancer. Wiley.
Chicago Style (17th ed.) CitationZhijian Kuang and Chun‐Ming Wong. Targeting CDK12 Is a Novel Therapeutic Strategy Through Disrupting Oncogene Associated Super‐enhancers in Metastatic Colorectal Cancer. Wiley, 2022.
MLA (9th ed.) CitationZhijian Kuang and Chun‐Ming Wong. Targeting CDK12 Is a Novel Therapeutic Strategy Through Disrupting Oncogene Associated Super‐enhancers in Metastatic Colorectal Cancer. Wiley, 2022.
Warning: These citations may not always be 100% accurate.